Seasonal coronavirus-specific B-cells with limited SARS-CoV-2 cross-reactivity dominate the IgG response in severe COVID-19 patients (Q110410631)
Jump to navigation
Jump to search
scholarly article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Seasonal coronavirus-specific B-cells with limited SARS-CoV-2 cross-reactivity dominate the IgG response in severe COVID-19 patients |
scholarly article |
Statements
Seasonal coronavirus-specific B-cells with limited SARS-CoV-2 cross-reactivity dominate the IgG response in severe COVID-19 patients (English)
0 references
Johannes P.C. van den Akker
0 references
Corine H. GeurtsvanKessel
0 references
9 September 2021
0 references
131
0 references
21
0 references